Skip to main content
. 2008 Aug 14;99(8):1679–1684. doi: 10.1111/j.1349-7006.2008.00857.x

Figure 3.

Figure 3

Surfactant protein‐A levels after lipopolysaccharide (LPS) instillation in the bronchoalveolar lavage (BAL) fluid. (a) Western blotting of SP‐A and ‐D and densitometric data of (b) SP‐A and (c) SP‐D in BAL fluid from mice with/without 7 days gefitinib pretreatment, 72 h after the intratracheal LPS instillation (250 µg/kg). (Inline graphic) mice receiving LPS only; (Inline graphic) mice receiving gefitinib and LPS. Data presents means ± standard error in five mice. *P < 0.05.